Speech-Language Pathologists in Mc Arthur, OH Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Mrs. Rondel Spires, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 307 W High St, Mc Arthur, OH 45651 Phone: 740-596-5128 |
Barbara Ann Martin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 507 Jefferson Ave, Mc Arthur, OH 45651 Phone: 740-596-4386 Fax: 740-596-4027 |
News Archive
Social determinants, inequality have negative impact on global health, WHO report says
Social inequalities such as inadequate education, a lack of human rights, poverty and poor housing negatively can impact global health conditions, according to a report released Thursday by the World Health Organization's Commission on the Social Determinants of Health, Toronto's Globe and Mail reports.
Top-line results from Probiodrug's PQ912 Phase 1 SAD, MAD study for Alzheimer's disease
Probiodrug AG, a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and multiple ascending dose (MAD) study of PQ912 in healthy volunteers.
Large safety gaps identified between top and bottom performing hospitals
The 2009 HealthGrades Patient Safety Excellence Award™ recipients were identified in a report issued today by the leading independent healthcare ratings organization.
Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
FDA approves a hybrid closed loop diabetes management device for young pediatric patients
Today, the U.S. Food and Drug Administration approved the MiniMed 770G System, a hybrid closed loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the users or their caregivers for use by individuals aged 2 to 6 with type 1 diabetes.
› Verified 6 days ago